Abdominal pain, a common presenting symptom in clinical practice, often poses a diagnostic challenge due to its multifaceted etiology. This article aims to provide a comprehensive approach to evaluating abdominal pain, enabling a more accurate and efficient diagnosis.
The initial assessment should focus on identifying life-threatening causes. The clinician should consider the patient's age, medical history, and the nature of the pain. Vital signs and physical examination can provide clues to the severity and potential causes. A detailed history, including the onset, location, and characteristics of the pain, should be obtained.
Based on the initial assessment, appropriate laboratory and imaging studies should be ordered. Routine tests may include complete blood count, liver function tests, and urinalysis. Imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) can provide further insights, especially when the cause is not apparent from the history and physical examination.
Special populations may require a different approach. In women, gynecological causes should be considered. In elderly patients, vascular causes are more common. In patients with a history of surgery, adhesions should be considered. In all cases, a high index of suspicion for serious causes should be maintained.
If the diagnosis remains elusive after initial evaluation, referral to a specialist may be necessary. Regardless of the cause, appropriate follow-up is crucial to ensure symptom resolution and to monitor for any potential complications.
Abdominal pain evaluation requires a systematic approach, considering the broad differential diagnosis. By maintaining a high index of suspicion for serious causes and tailoring the evaluation to the individual patient, clinicians can improve diagnostic accuracy and patient outcomes.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation